Notice ID: 35c3e9c6ef5344ab81ec6b927b2a9791Combined Synopsis/Solicitation
Amendment #0001 - Purchase of HPV Genotyping Assays and Testing Supplies
Archived on August 27, 2021. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM UTC−04:00
- Posted
- August 9, 2021
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NIH NCI
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75N91021Q00171
- Notice ID
- 35c3e9c6ef5344ab81ec6b927b2a9791
Description
August 9th, 2021 - Amendment #0001 of the solicitation hereby extends the response due date from August 6th, 2021 at 12:00 PM EST, to Thursday, August 12th, 2021 by 12:00 PM EST. All other stipulations set-forth in solicitation remain unchanged. __________________________________________________________________________________________________ The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG) has a need for five thousand two hundred (5200) Human Papillomavirus (HPV) genotyping test kits, two (2) polymerase chain reaction (PCR) systems, and eight hundred (800) cervical specimen collection kits. These kits will be utilized in support of ongoing research efforts of HPV. This is a Combined Synopsis/Solicitation for commercial items, prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, as supplemented with additional information included in this notice, and shall be processed in accordance with FAR Part 13 Simplified Acquisition Procedures. This announcement constitutes the only solicitation that will be provided in relation to the stated need contained herein. This solicitation, 75N91021Q00171, is issued as a request for quote (RFQ) and includes applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2021-06 (07/12/2021). This requirement is a Total Small Business Set-Aside the North American Industry Classification Code (NAICS) 325413 (In-Vitro Diagnostic Substance Manufacturing) for which the business size standard of 1,250 employees. One Firm-Fixed-Priced award is anticipated to be made in relation to this solicitation. *** Please reference the attached Combined Synopsis Solicitation document for additional details including the Statement of Need (SON), applicable clauses and provisions, submission instructions, and evaluation criteria. ***
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N91021Q00171- Combined Synopsis
- 3×Combined SynopsisCurrentJul 30, 2021
Amendment #0001 - Purchase of HPV Genotyping Assays and Testing Supplies
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N91021Q00171
Archive Date
Aug 27, 2021
Office Address
Bethesda, MD, 20892